GOSS
Price
$2.99
Change
-$0.21 (-6.56%)
Updated
Sep 17 closing price
Capitalization
727.62M
49 days until earnings call
TVTX
Price
$23.65
Change
+$0.88 (+3.86%)
Updated
Sep 17 closing price
Capitalization
2.03B
48 days until earnings call
Interact to see
Advertisement

GOSS vs TVTX

Header iconGOSS vs TVTX Comparison
Open Charts GOSS vs TVTXBanner chart's image
Gossamer Bio
Price$2.99
Change-$0.21 (-6.56%)
Volume$4.8M
Capitalization727.62M
Travere Therapeutics
Price$23.65
Change+$0.88 (+3.86%)
Volume$2.01M
Capitalization2.03B
GOSS vs TVTX Comparison Chart in %
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. TVTX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and TVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (GOSS: $2.99 vs. TVTX: $23.65)
Brand notoriety: GOSS and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 125% vs. TVTX: 101%
Market capitalization -- GOSS: $727.62M vs. TVTX: $2.03B
GOSS [@Biotechnology] is valued at $727.62M. TVTX’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 4 bearish.
  • TVTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GOSS and TVTX are a good buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а -3.86% price change this week, while TVTX (@Biotechnology) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

GOSS is expected to report earnings on Nov 06, 2025.

TVTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($2.03B) has a higher market cap than GOSS($728M). GOSS YTD gains are higher at: 230.533 vs. TVTX (35.763). TVTX has higher annual earnings (EBITDA): -107.65M vs. GOSS (-128.6M). TVTX has more cash in the bank: 320M vs. GOSS (213M). GOSS has less debt than TVTX: GOSS (203M) vs TVTX (400M). TVTX has higher revenues than GOSS: TVTX (334M) vs GOSS (40.2M).
GOSSTVTXGOSS / TVTX
Capitalization728M2.03B36%
EBITDA-128.6M-107.65M119%
Gain YTD230.53335.763645%
P/E RatioN/AN/A-
Revenue40.2M334M12%
Total Cash213M320M67%
Total Debt203M400M51%
FUNDAMENTALS RATINGS
GOSS vs TVTX: Fundamental Ratings
GOSS
TVTX
OUTLOOK RATING
1..100
2383
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
10084
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3439
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOSS's Valuation (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for TVTX (90) in the Biotechnology industry. This means that GOSS’s stock grew somewhat faster than TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to GOSS’s over the last 12 months.

TVTX's SMR Rating (100) in the Biotechnology industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to GOSS’s over the last 12 months.

GOSS's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as TVTX (39) in the Biotechnology industry. This means that GOSS’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for GOSS (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than GOSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSSTVTX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSBAX66.59N/A
N/A
Nuveen Dividend Growth A
TQMIX19.20N/A
N/A
AMG TimesSquare Mid Cap Growth I
MIDFX62.78N/A
N/A
Marsico Midcap Growth Focus Instl
DRISX19.23N/A
N/A
North Square Small Cap Value I
MKECX12.97N/A
N/A
BlackRock Emerging Markets Ex-China K

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with LITS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then LITS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-6.56%
LITS - GOSS
46%
Loosely correlated
-2.97%
APVO - GOSS
41%
Loosely correlated
-6.67%
ABEO - GOSS
40%
Loosely correlated
-0.79%
AUPH - GOSS
37%
Loosely correlated
-1.76%
SLDB - GOSS
36%
Loosely correlated
+1.48%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+3.86%
CRNX - TVTX
43%
Loosely correlated
+0.29%
ELVN - TVTX
40%
Loosely correlated
+3.17%
DNLI - TVTX
39%
Loosely correlated
-1.51%
XNCR - TVTX
38%
Loosely correlated
+7.31%
OCUL - TVTX
38%
Loosely correlated
-2.17%
More